Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03044171Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by Universidade Federal do Pará. Primary endpoint: Stimulated pain intensity measure (P5) at 4 weeks. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03044171.